0
Signin
countryflagUS

18889881171

AAPL 169.89 0.5147% MSFT 399.04 -2.4495% GOOG 157.95 -1.9553% GOOGL 156.0 -1.9669% AMZN 173.67 -1.6535% NVDA 826.32 3.7087% META 441.38 -10.5613% TSLA 170.18 4.9652% TSM 136.58 2.7149% LLY 724.87 -1.0011% V 275.16 0.0509% AVGO 1294.42 2.9917% JPM 193.37 0.1502% UNH 493.86 1.3462% NVO 125.79 -0.2933% WMT 60.21 0.5679% LVMUY 167.91 -2.1618% XOM 121.35 0.2478% LVMHF 837.0 -2.6461% MA 462.11 -0.0843%

Intuitive Surgical Inc

Healthcare US ISRG

373.12USD
-1.89(0.50%)

Last update at 2024-04-25T20:04:00Z

Day Range

367.66375.46
LowHigh

52 Week Range

222.65358.07
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 1606.80M 1890.30M 1207.00M 1502.20M 1279.50M
Minority interest -22.10000M -23.50000M 6.20M 2.50M -2.90000M
Net income 1322.30M 1704.60M 1060.60M 1379.30M 1127.90M
Selling general administrative 1739.90M 1466.50M 1216.00M 1178.40M 986.60M
Selling and marketing expenses - - - - -
Gross profit 4196.00M 3958.50M 2861.20M 3110.20M 2604.10M
Reconciled depreciation 365.80M 310.20M 276.20M 203.00M 122.80M
Ebit 1211.30M 1510.80M 773.60M 1171.50M 1076.60M
Ebitda 1577.10M 1821.00M 1049.80M 1374.50M 1199.40M
Depreciation and amortization 365.80M 310.20M 276.20M 203.00M 122.80M
Non operating income net other 29.70M 69.30M 157.20M 127.70M 80.10M
Operating income 1211.30M 1821.00M 773.60M 1374.50M 1199.40M
Other operating expenses 4645.10M 3889.10M 3308.60M 3104.00M 2524.80M
Interest expense 29.70M 356.00M 427.20M 328.20M 0.00000M
Tax provision 262.40M 162.20M 140.20M 120.40M 154.50M
Interest income 29.70M 69.30M 157.20M 127.70M 80.10M
Net interest income 29.70M 69.30M 157.20M 127.70M 80.10M
Extraordinary items - - - - -0.50000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 262.40M 162.20M 140.20M 120.40M 154.50M
Total revenue 6222.20M 5710.10M 4358.40M 4478.50M 3724.20M
Total operating expenses 2618.90M 2137.50M 1811.40M 1735.70M 1404.70M
Cost of revenue 2026.20M 1751.60M 1497.20M 1368.30M 1120.10M
Total other income expense net 395.50M 69.30M 433.40M 127.70M 80.10M
Discontinued operations - - - - -
Net income from continuing ops 1344.40M 1728.10M 1066.80M 1381.80M 1125.00M
Net income applicable to common shares 1322.30M 1704.60M 1060.60M 1379.30M 1127.90M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 12974.00M 13555.00M 11168.90M 9733.20M 7846.70M
Intangible assets 49.80M 70.50M 77.40M 112.10M 66.70M
Earning assets - - - - -
Other current assets 164.30M 271.10M 267.50M 200.20M 178.80M
Total liab 1861.40M 1603.50M 1409.80M 1448.50M 1159.20M
Total stockholder equity 11112.60M 11951.50M 9759.10M 8284.70M 6687.50M
Deferred long term liab 72.30M 71.80M 53.10M 51.50M 34.20M
Other current liab 1276.10M 1068.30M 945.80M 568.90M 692.10M
Common stock 0.40M 0.40M 0.10M 0.10M 0.10M
Capital stock 0.40M 0.40M 0.10M 0.10M 0.10M
Retained earnings 3500.10M 4760.90M 3261.30M 2494.50M 1521.70M
Other liab 369.70M 414.00M 386.60M 349.60M 338.60M
Good will 348.50M 343.60M 336.70M 307.20M 240.60M
Other assets 1183.60M 13555.00M 2127.00M 680.50M 622.90M
Cash 1581.20M 1290.90M 1622.60M 1167.60M 4834.40M
Cash and equivalents - - - - -
Total current liabilities 1861.40M 1603.50M 1409.80M 1448.50M 1159.20M
Current deferred revenue 438.30M 414.00M 382.40M 365.20M 327.30M
Net debt -1581.20000M -1203.90000M -1622.60000M -1167.60000M -4834.40000M
Short term debt - - - -568.90000M 39.10M
Short long term debt - - - - -
Short long term debt total - 87.00M - - -
Other stockholder equity 7774.60M 7214.40M 6472.80M 5777.70M 5170.30M
Property plant equipment 2374.20M 1876.40M 1577.30M 1272.90M 812.00M
Total current assets 8576.80M 9989.30M 8116.10M 7511.50M 6354.30M
Long term investments 2623.60M 4415.50M 1757.70M 2623.50M 1771.30M
Net tangible assets 9983.30M 11607.90M 8891.20M 7515.20M 6177.20M
Short term investments 2541.00M 2940.00M 3548.90M 2054.10M 2205.20M
Net receivables 942.10M 782.70M 645.50M 645.20M 682.30M
Long term debt - - - - -
Inventory 893.20M 587.10M 601.50M 595.50M 409.00M
Accounts payable 147.00M 121.20M 81.60M 1083.30M 100.70M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity 70.70M 50.40M 27.60M 20.90M 8.70M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -162.50000M -24.20000M 24.90M 12.40M -13.30000M
Additional paid in capital - - - - -
Common stock total equity 0.40M 0.40M 0.10M 0.10M 0.10M
Preferred stock total equity - - - - -
Retained earnings total equity 3500.10M 4760.90M 3261.30M 2494.50M 1521.70M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -1613.70000M -3511.20000M -986.60000M -2407.50000M -1760.10000M
Deferred long term asset charges - - - 425.60M 428.60M
Non current assets total 4397.20M 3565.70M 3052.80M 2221.70M 1492.40M
Capital lease obligations - 87.00M - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 1916.00M -2099.30000M -561.40000M -669.10000M -774.30000M
Change to liabilities 216.00M 235.10M 3.00M -117.10000M 134.30M
Total cashflows from investing activities 1370.80M -2461.50000M -940.60000M -1154.40000M -1049.60000M
Net borrowings - - - - -
Total cash from financing activities -2572.30000M 43.00M -85.70000M -168.40000M 126.30M
Change to operating activities 44.00M -38.40000M -91.50000M -47.60000M -14.40000M
Net income 1344.40M 1728.10M 1066.80M 1381.80M 1125.00M
Change in cash 294.70M -332.50000M 455.90M 273.20M 246.20M
Begin period cash flow 1306.00M 1638.50M 1182.60M 909.40M 663.20M
End period cash flow 1600.70M 1306.00M 1638.50M 1182.60M 909.40M
Total cash from operating activities 1490.80M 2089.40M 1484.80M 1598.20M 1169.60M
Issuance of capital stock - - - - -
Depreciation 365.80M 310.20M 276.20M 203.00M 122.80M
Other cashflows from investing activities -12.80000M -8.70000M -37.70000M -59.70000M -87.90000M
Dividends paid - - - - -
Change to inventory -546.60000M -256.00000M -170.10000M -360.50000M -279.00000M
Change to account receivables -159.30000M -142.30000M 5.70M 38.80M -161.30000M
Sale purchase of stock -2607.40000M 276.50M -134.30000M -269.50000M 236.60M
Other cashflows from financing activities -198.70000M -233.50000M -260.20000M -171.70000M -110.30000M
Change to netincome 324.10M 386.60M 453.00M -327.80000M 293.10M
Capital expenditures 532.40M 353.50M 341.50M 425.60M 187.40M
Change receivables -159.30000M -142.30000M 5.70M -38.80000M -161.30000M
Cash flows other operating 235.40M 99.90M 131.70M -56.20000M 41.50M
Exchange rate changes - -3.40000M -2.60000M -2.20000M -0.10000M
Cash and cash equivalents changes 289.30M -332.50000M 455.90M -2923.20000M 246.20M
Change in working capital -619.10000M -368.10000M -273.20000M -321.50000M -383.70000M
Stock based compensation 513.20M 449.20M 395.40M 335.80M 261.20M
Other non cash items 71.80M 32.60M -38.00000M 7.10M 12.40M
Free cash flow 958.40M 1735.90M 1143.30M 1172.60M 982.20M

Fundamentals

  • Previous Close 375.01
  • Market Cap114574.79M
  • Volume1243852
  • P/E Ratio76.39
  • Dividend Yield0.19%
  • EBITDA2110.00M
  • Revenue TTM6850.80M
  • Revenue Per Share TTM19.52
  • Gross Profit TTM 4196.00M
  • Diluted EPS TTM4.26

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ISRG
Intuitive Surgical Inc		 -1.89 0.50% 373.12 76.39 50.76 16.72 9.14 16.12 52.74
ESLOY
Essilor International SA		 -1.2204 1.11% 108.48 35.39 24.81 3.63 2.20 4.00 16.25
ESLOF
EssilorLuxottica Société anonyme		 -2.035 0.94% 214.74 35.71 25.13 3.62 2.23 4.00 16.25
BDX
Becton Dickinson and Company		 -3.35 1.43% 230.48 47.65 17.51 3.60 2.69 4.33 19.06
HOCPF
HOYA Corporation		 - -% 111.41 35.71 - 0.06 6.34 0.05 0.15

Reports Covered

Stock Research & News

View All

Profile

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical Inc

1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304

Key Executives

Name Title Year Born
Dr. Gary S. Guthart Ph.D. Pres, CEO & Director 1966
Mr. Marshall L. Mohr Exec. VP of Global Bus. Services 1956
Mr. David J. Rosa Exec. VP and Chief Strategy & Growth Officer 1968
Dr. Myriam J. Curet McAdams F.A.C.S., M.D. Exec. VP & Chief Medical Officer 1957
Mr. Robert DeSantis Exec. VP & Chief Product Officer 1966
Mr. Jamie E. Samath Sr. VP & CFO 1971
Mr. Fredrik Widman VP, Principal Accounting Officer & Corp. Controller NA
Mr. Philip Kim Head of Investor Relations NA
Mr. Gary Loeb Gen. Counsel & Chief Compliance Officer NA
Mr. Julian Nikolchev Sr. VP of Corp. Devel. & Strategy 1954

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).